The English defender has had a great season with the Spurs, and his leadership on the field has not gone unnoticed. Tottenham ...

Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral ...

GSK and Spero Therapeutics’ Phase III trial of their oral antibiotic for complicated urinary tract infections (cUTI) will end ...

Climate activist Greta Thunberg and 11 others set sail Sunday from southern Italy aboard a vessel aimed at breaking Israel’s ...

LLY to acquire SiteOne for up to $1 billion. GSK's antibiotic study ends early for efficacy. MRNA loses H5 flu vaccine ...

Cristian Romero will push to leave Tottenham Hotspur this summer if they sack Ange Postecoglou, with the defender linked to Atletico Madrid.

Tottenham hope that Champions League football and a new contract can convince Cuti Romero to remain at the club this summer ...

According to Trip.Best, Sunway Lagoon Theme Park, Genting SkyWorlds Theme Park, and Underwater World Langkawi are among some ...

The Ecuadorian center-back has become one of Diego Pablo Simeone's new desires.

"Complicated UTIs can have a profound impact on patients and carry a high risk of clinical complications, including sepsis and septic shock," said GSK Chief Scientific Officer Tony Wood. "These ...

Tottenham Hotspur star Cristian Romero has been repeatedly linked to Atlético Madrid. The Argentina international played a ...

If approved, tebipenem HBr could become the first oral carbapenem antibiotic available in the US for cUTI patients, potentially altering the current treatment landscape which heavily relies on ...